Gaps in diagnostic testing, treatment and funding are undermining global efforts to combat antimicrobial resistance (AMR), leaving millions of patients vulnerable to drug resistant infections, the World Health Organisation (WHO) has warned.
In a statement, WHO Director-General, Dr Tedros Ghebreyesus said antimicrobial resistance is making common infections increasingly difficult to treat, while raising the risks associated with surgery, childbirth and cancer care.
“When medicines lose their effectiveness against resistant microbes, common infections become harder to treat, while surgery, childbirth and cancer care become riskier,” he said, noting that, “In 2023, one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotics.”
The warning comes as the world prepares to mark World AMR Awareness Week from November 18 to 24, under the theme “One Health, one action: Prevent AMR now.”
World AMR Awareness Week is a global campaign to raise awareness of AMR and promote action to prevent the emergence and spread of drug-resistant infections.
Under the 2026 theme, “One Health, one action: Prevent AMR now”, the campaign highlights the interconnected health of people, animals, plants and the environment, and calls on everyone from governments to farmers, veterinarians, environmental experts and communities to take action to prevent AMR.
According to the new survey, 173 countries report having developed plans to address AMR, more than double the 79 countries that reported doing…